DNA and glutathione interactions in cell-free media of asymmetric platinum(II) complexes cis- and trans-[PtCl2(isopropylamine)(1- methylimidazole)]: Relations to their different antitumor effects

Journal of Biological Inorganic Chemistry

Volumn 14, Issue 1, 2009, Pages 75-87

  Suchánková, Tereza ^a   Vojtíšková, Marie ^a   Reedijk, Jan ^b   Brabec, Viktor ^a,c   Kašpárková, Jana ^a  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

^b LEIDEN UNIVERSITY   (Netherlands)

^c PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Antitumor activity; Cisplatin; Conformation; DNA; Transplatin

Indexed keywords

1 METHYLIMIDAZOLE; CISPLATIN; DNA; GLUTATHIONE; HIGH MOBILITY GROUP B1 PROTEIN; PLATINUM; PYRROLE; TRANSPLATIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL FREE SYSTEM; CONTROLLED STUDY; CYTOTOXICITY; DNA BINDING; DNA MODIFICATION; DRUG ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN INTERACTION;

ANTINEOPLASTIC AGENTS; BINDING SITES; CELL-FREE SYSTEM; CIRCULAR DICHROISM; CULTURE MEDIA; DNA; GLUTATHIONE; HUMANS; ORGANOPLATINUM COMPOUNDS; SPECTROPHOTOMETRY, ULTRAVIOLET; STEREOISOMERISM;

MAMMALIA;

EID: 57149129574     PISSN: 09498257     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00775-008-0425-0     Document Type: Article

References (52)

1. Reedijk J (1996) Chem Commun 801-806
2. Farrell N (1996) In: Sigel A, Sigel H (eds) Metal ions in biological systems. Marcel Dekker, New York, pp 603-639
3. J-M Perez MA Fuertes C Alonso C Navarro-Ranninger 2000 Crit Rev Oncol Hematol 35 109 120
4. V Brabec 2002 Prog Nucleic Acid Res Mol Biol 71 1 68
5. M Coluccia G Natile 2007 Anticancer Agents Med Chem 7 111 123
6. SW Johnson KV Ferry TC Hamilton 1998 Drug Resist Updat 1 243 254
7. V Brabec J Kasparkova 2005 Drug Resist Updat 8 131 146
8. ELM Lempers K Inagaki J Reedijk 1988 Inorganica Chim Acta 152 201 207
9. ELM Lempers J Reedijk 1990 Inorg Chem 29 217 222
10. Leng M, Schwartz A, Giraud-Panis MJ (2000) In: Kelland LR, Farrell NP (eds) Platinum-based drugs in cancer therapy. Humana Press, Totowa, pp 63-85
11. Brabec V, Kasparkova J (2005) In: Perez-Martin J-M, Fuertes MA, Alonso C (eds) Metal compounds in cancer chemotherapy. Research Signpost, Trivandrum, Kerala, India, pp 187-218
12. E Pantoja A Gallipoli S van Zutphen S Komeda D Reddy D Jaganyi M Lutz DM Tooke AL Spek C Navarro-Ranninger J Reedijk 2006 J Inorg Biochem 100 1955 1964
13. E Pantoja A Gallipoli S van Zutphen DM Tooke AL Spek C Navarro-Ranninger J Reedijk 2006 Inorganica Chim Acta 359 4335 4342
14. V Brabec E Palecek 1976 Biophys Chem 4 76 92
15. M Stros J Reich A Kolibalova 1994 FEBS Lett 344 201 206
16. JL Manley A Fire A Cano PA Sharp ML Gefter 1980 Proc Natl Acad Sci USA 77 3855 3859
17. JT Reardon A Vaisman SG Chaney A Sancar 1999 Cancer Res 59 3968 3971
18. SD Kim O Vrana V Kleinwächter K Niki V Brabec 1990 Anal Lett 23 1505 1518
19. MV Keck SJ Lippard 1992 J Am Chem Soc 114 3386 3390
20. D Hagrman J Goodisman JC Dabrowiak AK Souid 2003 Drug Metab Dispos 31 916 923
21. J Kasparkova O Novakova O Vrana F Intini G Natile V Brabec 2006 Mol Pharmacol 70 1708 1719
22. DP Bancroft CA Lepre SJ Lippard 1990 J Am Chem Soc 112 6860 6871
23. Brabec V (2000) In: Kelland LR, Farrell NP (eds) Platinum-based drugs in cancer therapy, Humana Press, Totowa, pp 37-61
24. V Brabec M Leng 1993 Proc Natl Acad Sci USA 90 5345 5349
25. NP Johnson J-L Butour G Villani FL Wimmer M Defais V Pierson V Brabec 1989 Prog Clin Biochem Med 10 1 24
26. V Brabec V Kleinwächter JL Butour NP Johnson 1990 Biophys Chem 35 129 141
27. AMJ Fichtinger-Schepman RA Baan F Berends 1989 Carcinogenesis 10 2367 2369
28. A Eastman 1987 Pharmacol Ther 34 155 166
29. A Eastman MA Barry 1987 Biochemistry 26 3303 3307
30. J Kasparkova V Marini Y Najajreh D Gibson V Brabec 2003 Biochemistry 42 6321 6332
31. FJ Ramos-Lima O Vrana AG Quiroga C Navarro-Ranninger A Halamikova H Rybnickova L Hejmalova V Brabec 2006 J Med Chem 49 2640 2651
32. GL Cohen WR Bauer JK Barton SJ Lippard 1979 Science 203 1014 1016
33. WM Scovell F Collart 1985 Nucleic Acids Res 13 2881 2895
34. R Zaludova A Zakovska J Kasparkova Z Balcarova V Kleinwächter O Vrana N Farrell V Brabec 1997 Eur J Biochem 246 508 517
35. R Zaludova V Kleinwächter V Brabec 1996 Biophys Chem 60 135 142
36. UM Ohndorf MA Rould Q He CO Pabo SJ Lippard 1999 Nature 399 708 712
37. M Kartalou JM Essigmann 2001 Mutat Res 478 1 21
38. SM Cohen SJ Lippard 2001 Prog Nucleic Acid Res Mol Biol 67 93 130
39. EN Hughes BN Engelsberg PC Billings 1992 J Biol Chem 267 13520 13527
40. PM Pil SJ Lippard 1992 Science 256 234 237
41. JJ Turchi M Li KM Henkels 1996 Biochemistry 35 2992 3000
42. J Reedijk 1999 Chem Rev 99 2499 2510
43. X Wang Z Guo 2007 Anticancer Agents Med Chem 7 19 34
44. O Vrana V Brabec V Kleinwächter 1986 Anticancer Drug Des 1 95 109
45. N Farrell LR Kelland JD Roberts M Van Beusichem 1992 Cancer Res 52 5065 5072
46. Natile G, Coluccia M (1999) In: Clarke MJ, Sadler PJ (eds) Metallopharmaceuticals. Springer, Berlin, pp 73-98
47. V Brabec J Kasparkova 2002 Drug Resist Updat 5 147 161
48. J Kasparkova J Zehnulova N Farrell V Brabec 2002 J Biol Chem 277 48076 48086
49. MA Lemaire A Schwartz AR Rahmouni M Leng 1991 Proc Natl Acad Sci USA 88 1982 1985
50. AMJ Fichtinger-Schepman JL Van der Veer JHJ Den Hartog PHM Lohman J Reedijk 1985 Biochemistry 24 707 713
51. FS Mackay JA Woods P Heringova J Kasparkova AM Pizarro SA Moggach S Parsons V Brabec PJ Sadler 2007 Proc Natl Acad Sci USA 104 20743 20748
52. Y Najajreh J Kasparkova V Marini D Gibson V Brabec 2005 J Biol Inorg Chem 10 722 731